

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 8.27234780 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.82684627 |
| 3 | muscle filament sliding (GO:0030049) | 7.82684627 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.25184684 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 7.10908389 |
| 6 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 6.75496231 |
| 7 | skeletal muscle contraction (GO:0003009) | 6.49489702 |
| 8 | actin-mediated cell contraction (GO:0070252) | 6.47020634 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 6.13784288 |
| 10 | neuronal action potential propagation (GO:0019227) | 5.95354665 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.59071408 |
| 12 | relaxation of smooth muscle (GO:0044557) | 5.55863379 |
| 13 | sodium ion export (GO:0071436) | 5.52454199 |
| 14 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.45646143 |
| 15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.40848350 |
| 16 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.19600687 |
| 17 | striated muscle contraction (GO:0006941) | 5.06977989 |
| 18 | skeletal muscle tissue regeneration (GO:0043403) | 4.96927001 |
| 19 | skeletal muscle adaptation (GO:0043501) | 4.81859343 |
| 20 | actin filament-based movement (GO:0030048) | 4.76761812 |
| 21 | tricarboxylic acid cycle (GO:0006099) | 4.60059345 |
| 22 | cardiac myofibril assembly (GO:0055003) | 4.59731364 |
| 23 | skeletal muscle tissue development (GO:0007519) | 4.51089375 |
| 24 | NADH metabolic process (GO:0006734) | 4.50456337 |
| 25 | actomyosin structure organization (GO:0031032) | 4.48992472 |
| 26 | membrane depolarization during action potential (GO:0086010) | 4.45211980 |
| 27 | glycogen catabolic process (GO:0005980) | 4.44293260 |
| 28 | response to activity (GO:0014823) | 4.42330521 |
| 29 | cell communication by electrical coupling (GO:0010644) | 4.41972058 |
| 30 | striated muscle atrophy (GO:0014891) | 4.27811931 |
| 31 | purine nucleotide salvage (GO:0032261) | 4.21202875 |
| 32 | oxaloacetate metabolic process (GO:0006107) | 4.21176197 |
| 33 | cardiac muscle contraction (GO:0060048) | 4.20153098 |
| 34 | glucan catabolic process (GO:0009251) | 4.12955489 |
| 35 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.10974247 |
| 36 | carnitine shuttle (GO:0006853) | 4.08323446 |
| 37 | cardiac muscle hypertrophy (GO:0003300) | 4.05811265 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 4.03671694 |
| 39 | skeletal muscle fiber development (GO:0048741) | 4.02099055 |
| 40 | glycolytic process (GO:0006096) | 4.01818774 |
| 41 | striated muscle hypertrophy (GO:0014897) | 3.98760740 |
| 42 | synaptic vesicle exocytosis (GO:0016079) | 3.94409588 |
| 43 | cellular polysaccharide catabolic process (GO:0044247) | 3.94325678 |
| 44 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.93497543 |
| 45 | relaxation of muscle (GO:0090075) | 3.92603170 |
| 46 | muscle cell fate commitment (GO:0042693) | 3.91283492 |
| 47 | muscle atrophy (GO:0014889) | 3.87919352 |
| 48 | muscle adaptation (GO:0043500) | 3.87436563 |
| 49 | sarcomere organization (GO:0045214) | 3.85083882 |
| 50 | calcium ion import (GO:0070509) | 3.84064213 |
| 51 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.83006585 |
| 52 | muscle structure development (GO:0061061) | 3.82237261 |
| 53 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.82067717 |
| 54 | response to muscle activity (GO:0014850) | 3.81905968 |
| 55 | succinate metabolic process (GO:0006105) | 3.80767653 |
| 56 | muscle organ development (GO:0007517) | 3.80687552 |
| 57 | positive regulation of myotube differentiation (GO:0010831) | 3.79403046 |
| 58 | fructose metabolic process (GO:0006000) | 3.75640442 |
| 59 | muscle contraction (GO:0006936) | 3.72200059 |
| 60 | polysaccharide catabolic process (GO:0000272) | 3.70535506 |
| 61 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.63128037 |
| 62 | myotube cell development (GO:0014904) | 3.58243124 |
| 63 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.57608398 |
| 64 | plasma membrane repair (GO:0001778) | 3.57573642 |
| 65 | muscle hypertrophy (GO:0014896) | 3.57081093 |
| 66 | gluconeogenesis (GO:0006094) | 3.54244075 |
| 67 | muscle fiber development (GO:0048747) | 3.49787497 |
| 68 | striated muscle cell development (GO:0055002) | 3.45888841 |
| 69 | muscle organ morphogenesis (GO:0048644) | 3.43011779 |
| 70 | myofibril assembly (GO:0030239) | 3.42490616 |
| 71 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.39008304 |
| 72 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.39008304 |
| 73 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.38331834 |
| 74 | muscle system process (GO:0003012) | 3.38089332 |
| 75 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.36204178 |
| 76 | cellular sodium ion homeostasis (GO:0006883) | 3.35609689 |
| 77 | cellular potassium ion homeostasis (GO:0030007) | 3.33548483 |
| 78 | synaptic vesicle maturation (GO:0016188) | 3.32333232 |
| 79 | neuromuscular synaptic transmission (GO:0007274) | 3.31753939 |
| 80 | muscle cell cellular homeostasis (GO:0046716) | 3.31704228 |
| 81 | lactate metabolic process (GO:0006089) | 3.30312130 |
| 82 | creatine metabolic process (GO:0006600) | 3.27680646 |
| 83 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.27586461 |
| 84 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.25053631 |
| 85 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.24600446 |
| 86 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.24061757 |
| 87 | fatty acid transmembrane transport (GO:1902001) | 3.23521666 |
| 88 | striated muscle adaptation (GO:0014888) | 3.22284507 |
| 89 | regulation of sarcomere organization (GO:0060297) | 3.22079867 |
| 90 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.21309662 |
| 91 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.19150774 |
| 92 | muscle hypertrophy in response to stress (GO:0003299) | 3.19150774 |
| 93 | cardiac muscle adaptation (GO:0014887) | 3.19150774 |
| 94 | oxidative phosphorylation (GO:0006119) | 3.18856075 |
| 95 | glucan biosynthetic process (GO:0009250) | 3.18370939 |
| 96 | glycogen biosynthetic process (GO:0005978) | 3.18370939 |
| 97 | AMP metabolic process (GO:0046033) | 3.17914153 |
| 98 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.15804704 |
| 99 | respiratory electron transport chain (GO:0022904) | 3.15320059 |
| 100 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.14078933 |
| 101 | IMP metabolic process (GO:0046040) | 3.13920012 |
| 102 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.13369246 |
| 103 | hexose biosynthetic process (GO:0019319) | 3.12875711 |
| 104 | pyruvate metabolic process (GO:0006090) | 3.09119494 |
| 105 | ADP metabolic process (GO:0046031) | 3.08983671 |
| 106 | negative regulation of muscle contraction (GO:0045932) | 3.08591089 |
| 107 | relaxation of cardiac muscle (GO:0055119) | 3.08127877 |
| 108 | muscle cell development (GO:0055001) | 3.07354216 |
| 109 | response to caffeine (GO:0031000) | 3.06971913 |
| 110 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.06304209 |
| 111 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.05919847 |
| 112 | regulation of myoblast differentiation (GO:0045661) | 3.05070271 |
| 113 | glycogen metabolic process (GO:0005977) | 3.04068180 |
| 114 | electron transport chain (GO:0022900) | 3.03667273 |
| 115 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.03548130 |
| 116 | regulation of striated muscle contraction (GO:0006942) | 3.03033805 |
| 117 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.02704008 |
| 118 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.01890113 |
| 119 | ATP synthesis coupled proton transport (GO:0015986) | 3.01890113 |
| 120 | striated muscle tissue development (GO:0014706) | 3.00266651 |
| 121 | cellular glucan metabolic process (GO:0006073) | 2.97058948 |
| 122 | glucan metabolic process (GO:0044042) | 2.97058948 |
| 123 | 2-oxoglutarate metabolic process (GO:0006103) | 2.96711363 |
| 124 | heart process (GO:0003015) | 2.96204757 |
| 125 | heart contraction (GO:0060047) | 2.96204757 |
| 126 | regulation of cofactor metabolic process (GO:0051193) | 2.95918089 |
| 127 | regulation of coenzyme metabolic process (GO:0051196) | 2.95918089 |
| 128 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.94245232 |
| 129 | cardiac muscle cell development (GO:0055013) | 2.93999147 |
| 130 | regulation of membrane repolarization (GO:0060306) | 2.92312743 |
| 131 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.89695797 |
| 132 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.89650749 |
| 133 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.89650749 |
| 134 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.87456020 |
| 135 | regulation of muscle system process (GO:0090257) | 2.86164245 |
| 136 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.85576424 |
| 137 | muscle tissue morphogenesis (GO:0060415) | 2.85428052 |
| 138 | myoblast fusion (GO:0007520) | 2.83828320 |
| 139 | response to inactivity (GO:0014854) | 2.83586762 |
| 140 | cell communication involved in cardiac conduction (GO:0086065) | 2.82891721 |
| 141 | retinal rod cell development (GO:0046548) | 2.81899414 |
| 142 | positive regulation of cation channel activity (GO:2001259) | 2.80166052 |
| 143 | regulation of relaxation of muscle (GO:1901077) | 2.77286847 |
| 144 | regulation of actin filament-based movement (GO:1903115) | 2.76761277 |
| 145 | calcium ion transport into cytosol (GO:0060402) | 2.76634185 |
| 146 | detection of light stimulus involved in visual perception (GO:0050908) | 2.76391072 |
| 147 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.76391072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.70515030 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.66580731 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.63021361 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.20205507 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.86987717 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.79654401 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.69552484 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.60695870 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59674920 |
| 10 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.37002589 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.35276788 |
| 12 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.32749084 |
| 13 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.29425815 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.19745034 |
| 15 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.19200045 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16968340 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.15869019 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13882815 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13882815 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12997553 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07793628 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07138305 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.06706407 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.00993340 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98674081 |
| 26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.89065581 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.88588944 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.79953706 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78032597 |
| 30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77144579 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.74687141 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.73145422 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72968650 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.72361080 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.69319173 |
| 36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.69055125 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.66584901 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63090024 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.61484435 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59578412 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58871442 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58042204 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57806533 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52889145 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52503087 |
| 46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47423549 |
| 47 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.47415269 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.43827720 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43088336 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42711955 |
| 51 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.42678028 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41999565 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38652409 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37522185 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36431264 |
| 56 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32128365 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29720731 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27298575 |
| 59 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26538519 |
| 60 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26004001 |
| 61 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26004001 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25825641 |
| 63 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.25506167 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24712135 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.23917847 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.23411249 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22788819 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22615396 |
| 69 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.20569556 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19296380 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19296380 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18995697 |
| 73 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.18627033 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17903276 |
| 75 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.17733447 |
| 76 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16654817 |
| 77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15972289 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14754630 |
| 79 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.12444760 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12396980 |
| 81 | TBL1_22424771_ChIP-Seq_293T_Human | 1.12301790 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11957868 |
| 83 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.11712550 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11372483 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11228315 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10914563 |
| 87 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09630272 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09610107 |
| 89 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08761964 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08707708 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07972350 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07972350 |
| 93 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07757596 |
| 94 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07210768 |
| 95 | NFYB_21822215_ChIP-Seq_K562_Human | 1.06271093 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05364229 |
| 97 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04624621 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04495704 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03669828 |
| 100 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.03437499 |
| 101 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02695267 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02389811 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02032989 |
| 104 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.01637082 |
| 105 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00850100 |
| 106 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.00496698 |
| 107 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00431778 |
| 108 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98841987 |
| 109 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.98785676 |
| 110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97915618 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97716597 |
| 112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97445888 |
| 113 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97417917 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97267666 |
| 115 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96872724 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96551116 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96332877 |
| 118 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.95880915 |
| 119 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.95535971 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94488196 |
| 121 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.93708230 |
| 122 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.93440636 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93198270 |
| 124 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.92232135 |
| 125 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92213396 |
| 126 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91749059 |
| 127 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91513687 |
| 128 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.91128037 |
| 129 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.91093289 |
| 130 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90999861 |
| 131 | CBP_21632823_ChIP-Seq_H3396_Human | 0.90458786 |
| 132 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90219285 |
| 133 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.90214074 |
| 134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90141635 |
| 135 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.90122351 |
| 136 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.89624004 |
| 137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89615852 |
| 138 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89198358 |
| 139 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89090778 |
| 140 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.89045715 |
| 141 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.88054663 |
| 142 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87741966 |
| 143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87518048 |
| 144 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.87358619 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87304473 |
| 146 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87304473 |
| 147 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86965927 |
| 148 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85524603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.62940376 |
| 2 | MP0003646_muscle_fatigue | 5.14391793 |
| 3 | MP0000749_muscle_degeneration | 4.89874569 |
| 4 | MP0000751_myopathy | 4.18586726 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.05854681 |
| 6 | MP0005451_abnormal_body_composition | 3.40028676 |
| 7 | MP0004233_abnormal_muscle_weight | 3.35492183 |
| 8 | MP0000747_muscle_weakness | 3.30647499 |
| 9 | MP0002106_abnormal_muscle_physiology | 3.08563458 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.89895144 |
| 11 | MP0002269_muscular_atrophy | 2.82797089 |
| 12 | MP0000759_abnormal_skeletal_muscle | 2.77583858 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.74093485 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.61454404 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.56461483 |
| 16 | MP0005369_muscle_phenotype | 2.56124736 |
| 17 | MP0004130_abnormal_muscle_cell | 2.37998182 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.35050825 |
| 19 | MP0009046_muscle_twitch | 2.23572063 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.20067733 |
| 21 | MP0004215_abnormal_myocardial_fiber | 2.19214735 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 2.07729947 |
| 23 | MP0006035_abnormal_mitochondrial_morpho | 1.93974187 |
| 24 | MP0003221_abnormal_cardiomyocyte_apopto | 1.83813507 |
| 25 | MP0004270_analgesia | 1.79225639 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 1.67684669 |
| 27 | MP0003136_yellow_coat_color | 1.66558520 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 1.65238982 |
| 29 | MP0008775_abnormal_heart_ventricle | 1.64884298 |
| 30 | MP0002127_abnormal_cardiovascular_syste | 1.57928433 |
| 31 | MP0002064_seizures | 1.55228318 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.53930975 |
| 33 | MP0004510_myositis | 1.53413516 |
| 34 | MP0004484_altered_response_of | 1.45427043 |
| 35 | MP0008569_lethality_at_weaning | 1.39596070 |
| 36 | MP0002272_abnormal_nervous_system | 1.39315545 |
| 37 | MP0009745_abnormal_behavioral_response | 1.36866614 |
| 38 | MP0002090_abnormal_vision | 1.34583305 |
| 39 | MP0001486_abnormal_startle_reflex | 1.30715518 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.30297615 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.30142935 |
| 42 | MP0002972_abnormal_cardiac_muscle | 1.26607719 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.25985464 |
| 44 | MP0002108_abnormal_muscle_morphology | 1.25658790 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.25472059 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.24425761 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.22773406 |
| 48 | MP0003880_abnormal_central_pattern | 1.18526742 |
| 49 | MP0002063_abnormal_learning/memory/cond | 1.17921388 |
| 50 | MP0004142_abnormal_muscle_tone | 1.16119327 |
| 51 | MP0002822_catalepsy | 1.14613373 |
| 52 | MP0002734_abnormal_mechanical_nocicepti | 1.13093288 |
| 53 | MP0005266_abnormal_metabolism | 1.11183950 |
| 54 | MP0005330_cardiomyopathy | 1.08280009 |
| 55 | MP0003137_abnormal_impulse_conducting | 1.07026761 |
| 56 | MP0004085_abnormal_heartbeat | 1.05472922 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.04831162 |
| 58 | MP0003879_abnormal_hair_cell | 1.04411916 |
| 59 | MP0004043_abnormal_pH_regulation | 1.02928173 |
| 60 | MP0004858_abnormal_nervous_system | 1.02668772 |
| 61 | MP0009840_abnormal_foam_cell | 1.01453717 |
| 62 | MP0005410_abnormal_fertilization | 0.98394139 |
| 63 | MP0003045_fibrosis | 0.96154470 |
| 64 | MP0005171_absent_coat_pigmentation | 0.92443931 |
| 65 | MP0002572_abnormal_emotion/affect_behav | 0.91495897 |
| 66 | MP0001501_abnormal_sleep_pattern | 0.89862995 |
| 67 | MP0003122_maternal_imprinting | 0.87688830 |
| 68 | MP0001440_abnormal_grooming_behavior | 0.86590059 |
| 69 | MP0001968_abnormal_touch/_nociception | 0.86199304 |
| 70 | MP0002066_abnormal_motor_capabilities/c | 0.86064792 |
| 71 | MP0002184_abnormal_innervation | 0.85759584 |
| 72 | MP0005385_cardiovascular_system_phenoty | 0.85337667 |
| 73 | MP0001544_abnormal_cardiovascular_syste | 0.85337667 |
| 74 | MP0000733_abnormal_muscle_development | 0.82441299 |
| 75 | MP0001502_abnormal_circadian_rhythm | 0.81756463 |
| 76 | MP0003787_abnormal_imprinting | 0.79673009 |
| 77 | MP0001299_abnormal_eye_distance/ | 0.78439301 |
| 78 | MP0000566_synostosis | 0.77507923 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.77019287 |
| 80 | MP0006138_congestive_heart_failure | 0.76807313 |
| 81 | MP0001984_abnormal_olfaction | 0.76765173 |
| 82 | MP0005423_abnormal_somatic_nervous | 0.74981966 |
| 83 | MP0010630_abnormal_cardiac_muscle | 0.74943436 |
| 84 | MP0002557_abnormal_social/conspecific_i | 0.74624232 |
| 85 | MP0009672_abnormal_birth_weight | 0.72694461 |
| 86 | MP0002736_abnormal_nociception_after | 0.72691947 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.70792633 |
| 88 | MP0003195_calcinosis | 0.70049418 |
| 89 | MP0003123_paternal_imprinting | 0.69386468 |
| 90 | MP0002229_neurodegeneration | 0.68438589 |
| 91 | MP0005386_behavior/neurological_phenoty | 0.67758163 |
| 92 | MP0004924_abnormal_behavior | 0.67758163 |
| 93 | MP0002882_abnormal_neuron_morphology | 0.61010630 |
| 94 | MP0002735_abnormal_chemical_nociception | 0.59983493 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.59710035 |
| 96 | MP0005375_adipose_tissue_phenotype | 0.58117084 |
| 97 | MP0002971_abnormal_brown_adipose | 0.57858002 |
| 98 | MP0005670_abnormal_white_adipose | 0.57789547 |
| 99 | MP0002752_abnormal_somatic_nervous | 0.57500460 |
| 100 | MP0004134_abnormal_chest_morphology | 0.57450428 |
| 101 | MP0000372_irregular_coat_pigmentation | 0.56757532 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.56379709 |
| 103 | MP0005253_abnormal_eye_physiology | 0.56303859 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.55921332 |
| 105 | MP0004147_increased_porphyrin_level | 0.55766003 |
| 106 | MP0002909_abnormal_adrenal_gland | 0.55761322 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.55688779 |
| 108 | MP0010030_abnormal_orbit_morphology | 0.54862848 |
| 109 | MP0000534_abnormal_ureter_morphology | 0.54341588 |
| 110 | MP0001346_abnormal_lacrimal_gland | 0.53981790 |
| 111 | MP0005535_abnormal_body_temperature | 0.53534242 |
| 112 | MP0009697_abnormal_copulation | 0.53439223 |
| 113 | MP0005187_abnormal_penis_morphology | 0.53193165 |
| 114 | MP0000955_abnormal_spinal_cord | 0.52587394 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.51619923 |
| 116 | MP0003959_abnormal_lean_body | 0.49948862 |
| 117 | MP0004811_abnormal_neuron_physiology | 0.49813421 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.48057052 |
| 119 | MP0003718_maternal_effect | 0.44431394 |
| 120 | MP0000003_abnormal_adipose_tissue | 0.43898432 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.41565700 |
| 122 | MP0008789_abnormal_olfactory_epithelium | 0.41549099 |
| 123 | MP0000266_abnormal_heart_morphology | 0.40063273 |
| 124 | MP0002876_abnormal_thyroid_physiology | 0.38837597 |
| 125 | MP0003828_pulmonary_edema | 0.38381493 |
| 126 | MP0010368_abnormal_lymphatic_system | 0.37381090 |
| 127 | MP0001661_extended_life_span | 0.37170536 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.36846023 |
| 129 | MP0002138_abnormal_hepatobiliary_system | 0.36461753 |
| 130 | MP0002168_other_aberrant_phenotype | 0.36229440 |
| 131 | MP0000343_altered_response_to | 0.35481185 |
| 132 | MP0003633_abnormal_nervous_system | 0.34718236 |
| 133 | MP0006276_abnormal_autonomic_nervous | 0.32569562 |
| 134 | MP0004185_abnormal_adipocyte_glucose | 0.32011511 |
| 135 | MP0009764_decreased_sensitivity_to | 0.30935297 |
| 136 | MP0005166_decreased_susceptibility_to | 0.30565329 |
| 137 | MP0008877_abnormal_DNA_methylation | 0.30537827 |
| 138 | MP0004381_abnormal_hair_follicle | 0.29254945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 9.10306177 |
| 2 | Exercise-induced myalgia (HP:0003738) | 8.60759533 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 7.66395768 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.29954763 |
| 5 | Nemaline bodies (HP:0003798) | 6.84495046 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.97179988 |
| 7 | Myoglobinuria (HP:0002913) | 5.71431000 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 5.50150214 |
| 9 | Myopathic facies (HP:0002058) | 5.48346638 |
| 10 | Distal arthrogryposis (HP:0005684) | 5.42161079 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 5.05660858 |
| 12 | Round ear (HP:0100830) | 4.88988558 |
| 13 | Ulnar deviation of the wrist (HP:0003049) | 4.67570440 |
| 14 | Muscle stiffness (HP:0003552) | 4.60101043 |
| 15 | Rhabdomyolysis (HP:0003201) | 4.52522689 |
| 16 | Absent phalangeal crease (HP:0006109) | 4.13556875 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.13401286 |
| 18 | Difficulty running (HP:0009046) | 3.94083638 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 3.90384370 |
| 20 | Focal motor seizures (HP:0011153) | 3.90002229 |
| 21 | Myotonia (HP:0002486) | 3.86060264 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 3.84440887 |
| 23 | Muscle fiber splitting (HP:0003555) | 3.67686875 |
| 24 | Calcaneovalgus deformity (HP:0001848) | 3.65984211 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 3.44850918 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.39122749 |
| 27 | Congenital stationary night blindness (HP:0007642) | 3.35044350 |
| 28 | Febrile seizures (HP:0002373) | 3.29817204 |
| 29 | Deformed tarsal bones (HP:0008119) | 3.25351351 |
| 30 | Atonic seizures (HP:0010819) | 3.11140863 |
| 31 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.06756129 |
| 32 | Acute necrotizing encephalopathy (HP:0006965) | 2.89230190 |
| 33 | Bundle branch block (HP:0011710) | 2.87768320 |
| 34 | Shoulder girdle muscle weakness (HP:0003547) | 2.79435679 |
| 35 | Increased connective tissue (HP:0009025) | 2.77431102 |
| 36 | Scapular winging (HP:0003691) | 2.77125759 |
| 37 | Neuroendocrine neoplasm (HP:0100634) | 2.75134871 |
| 38 | Absence seizures (HP:0002121) | 2.72383619 |
| 39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.70730496 |
| 40 | Weak cry (HP:0001612) | 2.69342449 |
| 41 | Rimmed vacuoles (HP:0003805) | 2.67041161 |
| 42 | Bulbar palsy (HP:0001283) | 2.65766249 |
| 43 | Cholecystitis (HP:0001082) | 2.65079655 |
| 44 | Abnormal gallbladder physiology (HP:0012438) | 2.65079655 |
| 45 | Central scotoma (HP:0000603) | 2.61822335 |
| 46 | Pheochromocytoma (HP:0002666) | 2.60451900 |
| 47 | Neck muscle weakness (HP:0000467) | 2.59690925 |
| 48 | Malignant hyperthermia (HP:0002047) | 2.58241807 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.56629284 |
| 50 | Pelvic girdle muscle weakness (HP:0003749) | 2.55208055 |
| 51 | Popliteal pterygium (HP:0009756) | 2.51422073 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.51313180 |
| 53 | Hyperkalemia (HP:0002153) | 2.49979612 |
| 54 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.47878287 |
| 55 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.47878287 |
| 56 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.46346270 |
| 57 | Subaortic stenosis (HP:0001682) | 2.46346270 |
| 58 | Progressive macrocephaly (HP:0004481) | 2.44562771 |
| 59 | Exercise intolerance (HP:0003546) | 2.39673298 |
| 60 | Gowers sign (HP:0003391) | 2.39254500 |
| 61 | Hip contracture (HP:0003273) | 2.38450425 |
| 62 | Cholelithiasis (HP:0001081) | 2.35157856 |
| 63 | Acute encephalopathy (HP:0006846) | 2.31384617 |
| 64 | Sudden death (HP:0001699) | 2.31227721 |
| 65 | Generalized tonic-clonic seizures (HP:0002069) | 2.30662086 |
| 66 | Progressive muscle weakness (HP:0003323) | 2.29546593 |
| 67 | Oligomenorrhea (HP:0000876) | 2.27921640 |
| 68 | Dilated cardiomyopathy (HP:0001644) | 2.27456114 |
| 69 | Epileptic encephalopathy (HP:0200134) | 2.27184418 |
| 70 | Hepatocellular necrosis (HP:0001404) | 2.26781605 |
| 71 | Mitochondrial inheritance (HP:0001427) | 2.26375431 |
| 72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26096851 |
| 73 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.25586828 |
| 74 | Distal lower limb muscle weakness (HP:0009053) | 2.24684271 |
| 75 | Limb-girdle muscle atrophy (HP:0003797) | 2.22974909 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.22558162 |
| 77 | Spinal rigidity (HP:0003306) | 2.15798706 |
| 78 | Type 2 muscle fiber atrophy (HP:0003554) | 2.12353465 |
| 79 | EMG: neuropathic changes (HP:0003445) | 2.11737933 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.10709513 |
| 81 | Heart block (HP:0012722) | 2.10443175 |
| 82 | Slender build (HP:0001533) | 2.06494983 |
| 83 | Paralysis (HP:0003470) | 2.06221945 |
| 84 | Visual hallucinations (HP:0002367) | 2.04677271 |
| 85 | Hepatic necrosis (HP:0002605) | 2.03992003 |
| 86 | Nonprogressive disorder (HP:0003680) | 2.03715807 |
| 87 | Dialeptic seizures (HP:0011146) | 2.03635882 |
| 88 | Gout (HP:0001997) | 2.03386421 |
| 89 | Difficulty climbing stairs (HP:0003551) | 2.02894523 |
| 90 | Frequent falls (HP:0002359) | 2.00924933 |
| 91 | Increased CSF lactate (HP:0002490) | 1.99396085 |
| 92 | Prolonged QT interval (HP:0001657) | 1.98024887 |
| 93 | Increased purine levels (HP:0004368) | 1.97731976 |
| 94 | Hyperuricemia (HP:0002149) | 1.97731976 |
| 95 | Abnormality of the calcaneus (HP:0008364) | 1.96192223 |
| 96 | Metatarsus adductus (HP:0001840) | 1.95202307 |
| 97 | Increased serum pyruvate (HP:0003542) | 1.93349294 |
| 98 | Abnormality of glycolysis (HP:0004366) | 1.93349294 |
| 99 | Hemiparesis (HP:0001269) | 1.93347255 |
| 100 | Facial diplegia (HP:0001349) | 1.92767809 |
| 101 | Lipoatrophy (HP:0100578) | 1.92408462 |
| 102 | Abnormal atrioventricular conduction (HP:0005150) | 1.91056869 |
| 103 | Abnormality of the foot musculature (HP:0001436) | 1.90319384 |
| 104 | Muscle fiber atrophy (HP:0100295) | 1.89296262 |
| 105 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.85838053 |
| 106 | Distal lower limb amyotrophy (HP:0008944) | 1.83979467 |
| 107 | Abnormality of placental membranes (HP:0011409) | 1.80119604 |
| 108 | Amniotic constriction ring (HP:0009775) | 1.80119604 |
| 109 | Foot dorsiflexor weakness (HP:0009027) | 1.80110380 |
| 110 | Hypoplastic ischia (HP:0003175) | 1.76974661 |
| 111 | Palpitations (HP:0001962) | 1.75854171 |
| 112 | Fetal akinesia sequence (HP:0001989) | 1.75752715 |
| 113 | Waddling gait (HP:0002515) | 1.75064647 |
| 114 | Proximal amyotrophy (HP:0007126) | 1.74416854 |
| 115 | Limb-girdle muscle weakness (HP:0003325) | 1.74161179 |
| 116 | Fatigable weakness (HP:0003473) | 1.72014279 |
| 117 | Abnormality of the neuromuscular junction (HP:0003398) | 1.72014279 |
| 118 | Optic disc pallor (HP:0000543) | 1.70317569 |
| 119 | Difficulty walking (HP:0002355) | 1.69286030 |
| 120 | Ragged-red muscle fibers (HP:0003200) | 1.67727060 |
| 121 | Muscular dystrophy (HP:0003560) | 1.67714588 |
| 122 | Ventricular tachycardia (HP:0004756) | 1.67652750 |
| 123 | Left ventricular hypertrophy (HP:0001712) | 1.67289628 |
| 124 | Hypokalemia (HP:0002900) | 1.64136930 |
| 125 | Abnormality of potassium homeostasis (HP:0011042) | 1.64065551 |
| 126 | Generalized muscle weakness (HP:0003324) | 1.63483254 |
| 127 | Scotoma (HP:0000575) | 1.62686584 |
| 128 | Ulnar deviation of finger (HP:0009465) | 1.62055296 |
| 129 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.61866914 |
| 130 | Long clavicles (HP:0000890) | 1.60859776 |
| 131 | Myokymia (HP:0002411) | 1.60554922 |
| 132 | Focal seizures (HP:0007359) | 1.59955661 |
| 133 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.57373463 |
| 134 | Steppage gait (HP:0003376) | 1.54181484 |
| 135 | Limited hip movement (HP:0008800) | 1.51876964 |
| 136 | Aplasia of the musculature (HP:0100854) | 1.45538606 |
| 137 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.44720544 |
| 138 | Tarsal synostosis (HP:0008368) | 1.44361359 |
| 139 | Ventricular arrhythmia (HP:0004308) | 1.36498776 |
| 140 | Easy fatigability (HP:0003388) | 1.33381175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.32109653 |
| 2 | PHKG1 | 5.36097812 |
| 3 | PHKG2 | 5.36097812 |
| 4 | TTN | 4.21594729 |
| 5 | LATS1 | 4.20042581 |
| 6 | NME1 | 4.06877979 |
| 7 | NEK1 | 3.96984881 |
| 8 | MAP3K7 | 2.37450481 |
| 9 | PINK1 | 2.34453057 |
| 10 | PDK3 | 2.32842748 |
| 11 | PDK4 | 2.32842748 |
| 12 | PIK3CG | 2.27118678 |
| 13 | MAP2K4 | 2.03924252 |
| 14 | MAP2K3 | 1.93205221 |
| 15 | MOS | 1.75987905 |
| 16 | CDK8 | 1.70004449 |
| 17 | INSRR | 1.69536444 |
| 18 | MAP3K4 | 1.61816137 |
| 19 | MAPKAPK3 | 1.53167568 |
| 20 | PIK3CA | 1.52388073 |
| 21 | NTRK3 | 1.48206148 |
| 22 | RIPK1 | 1.44689466 |
| 23 | PDK2 | 1.27448346 |
| 24 | TAOK2 | 1.26903211 |
| 25 | MUSK | 1.18797202 |
| 26 | MAPK12 | 1.13538435 |
| 27 | MAP3K9 | 1.08533006 |
| 28 | MAP2K7 | 1.05147422 |
| 29 | MAP2K6 | 1.03607376 |
| 30 | PAK6 | 1.02342490 |
| 31 | CASK | 1.01952158 |
| 32 | MYLK | 0.97679459 |
| 33 | PRKAA1 | 0.96540926 |
| 34 | EEF2K | 0.94808635 |
| 35 | TIE1 | 0.94083739 |
| 36 | LATS2 | 0.93141054 |
| 37 | MINK1 | 0.93036558 |
| 38 | DMPK | 0.89738283 |
| 39 | MARK3 | 0.89075693 |
| 40 | PLK2 | 0.88161015 |
| 41 | STK3 | 0.86322342 |
| 42 | IRAK2 | 0.85352593 |
| 43 | CCNB1 | 0.83594870 |
| 44 | ERBB4 | 0.81586560 |
| 45 | FRK | 0.81077174 |
| 46 | LIMK1 | 0.80631335 |
| 47 | PRKAA2 | 0.77659049 |
| 48 | GRK7 | 0.76010468 |
| 49 | PRKCG | 0.73594155 |
| 50 | MARK1 | 0.73068408 |
| 51 | TNIK | 0.73025872 |
| 52 | ACVR1B | 0.71996379 |
| 53 | PRPF4B | 0.71929761 |
| 54 | AKT2 | 0.70747426 |
| 55 | CAMK4 | 0.70250382 |
| 56 | CAMK2G | 0.67787754 |
| 57 | AKT3 | 0.66965805 |
| 58 | NEK9 | 0.61497289 |
| 59 | STK38 | 0.61405370 |
| 60 | MAP3K1 | 0.61211475 |
| 61 | MAP3K12 | 0.60978082 |
| 62 | ZAK | 0.58716310 |
| 63 | PDPK1 | 0.58124024 |
| 64 | TGFBR2 | 0.56967441 |
| 65 | PAK3 | 0.56207653 |
| 66 | MAPK7 | 0.54445675 |
| 67 | NEK6 | 0.53898260 |
| 68 | ERBB3 | 0.53526809 |
| 69 | PRKACB | 0.50656523 |
| 70 | RPS6KA3 | 0.50627404 |
| 71 | PRKACA | 0.50566016 |
| 72 | ICK | 0.50478464 |
| 73 | CAMK2A | 0.49846813 |
| 74 | KSR1 | 0.49313042 |
| 75 | DYRK1A | 0.48582172 |
| 76 | STK24 | 0.48109163 |
| 77 | SGK1 | 0.47834711 |
| 78 | NLK | 0.47547295 |
| 79 | CDK5 | 0.47494528 |
| 80 | MAPK11 | 0.47462162 |
| 81 | CDC42BPA | 0.46734365 |
| 82 | CAMK2D | 0.46552626 |
| 83 | TRIB3 | 0.45198460 |
| 84 | BCKDK | 0.44895679 |
| 85 | PKN2 | 0.44794179 |
| 86 | EIF2AK3 | 0.44681324 |
| 87 | CAMK2B | 0.43610355 |
| 88 | EPHA4 | 0.41977137 |
| 89 | ARAF | 0.40892886 |
| 90 | MAP2K1 | 0.40874264 |
| 91 | PDK1 | 0.38048556 |
| 92 | IRAK3 | 0.37976741 |
| 93 | CDK4 | 0.37964533 |
| 94 | SGK223 | 0.37946941 |
| 95 | SGK494 | 0.37946941 |
| 96 | PTK6 | 0.36615418 |
| 97 | CDK14 | 0.36505828 |
| 98 | PRKG1 | 0.36391530 |
| 99 | STK38L | 0.36009070 |
| 100 | NTRK2 | 0.35956186 |
| 101 | FGFR1 | 0.34154808 |
| 102 | TNK2 | 0.33936519 |
| 103 | CDK15 | 0.33527047 |
| 104 | PRKCH | 0.33257578 |
| 105 | MAPK4 | 0.32314673 |
| 106 | BRAF | 0.32030170 |
| 107 | CDK18 | 0.31773396 |
| 108 | ROCK1 | 0.31528008 |
| 109 | PTK2B | 0.31198387 |
| 110 | GRK5 | 0.31129964 |
| 111 | MELK | 0.31054510 |
| 112 | CAMK1 | 0.30964868 |
| 113 | SGK2 | 0.29354655 |
| 114 | SGK3 | 0.29065383 |
| 115 | DDR2 | 0.28980424 |
| 116 | PRKD1 | 0.28116731 |
| 117 | NUAK1 | 0.27973063 |
| 118 | MAPK13 | 0.27720321 |
| 119 | ADRBK2 | 0.27660571 |
| 120 | PKN1 | 0.27099372 |
| 121 | DAPK2 | 0.26190189 |
| 122 | IRAK1 | 0.25270737 |
| 123 | PRKD3 | 0.25152341 |
| 124 | CDK11A | 0.24674514 |
| 125 | PRKCA | 0.24449178 |
| 126 | MAP2K2 | 0.23291017 |
| 127 | MAP3K13 | 0.23185921 |
| 128 | BMPR1B | 0.22605965 |
| 129 | PRKCB | 0.22579061 |
| 130 | CAMKK2 | 0.22483324 |
| 131 | PRKCE | 0.22355564 |
| 132 | CDK3 | 0.22343043 |
| 133 | TRPM7 | 0.20925935 |
| 134 | RPS6KB1 | 0.20838606 |
| 135 | CDK19 | 0.20605806 |
| 136 | PRKACG | 0.19752907 |
| 137 | KSR2 | 0.19590229 |
| 138 | NEK2 | 0.19261242 |
| 139 | MAPK10 | 0.18093116 |
| 140 | MAPKAPK5 | 0.17372306 |
| 141 | TGFBR1 | 0.17212347 |
| 142 | CSNK1D | 0.14628747 |
| 143 | PAK1 | 0.13586159 |
| 144 | DYRK1B | 0.13285826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.04119770 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.52346791 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.99489908 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.90667967 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.65071139 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.56685579 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.50621539 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.49682807 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.31288039 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.20396712 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.12839724 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09456124 |
| 13 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.07617111 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.02211506 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.97645599 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.93374251 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.93358383 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.90122351 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.85565334 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80593507 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78722658 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.75861093 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.70588709 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.69921615 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.69627672 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.66677043 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63521300 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.62294953 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.62081682 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.43355445 |
| 31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.39294142 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39206630 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38991182 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.34870207 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30890473 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30432265 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.27223770 |
| 38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22645317 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.21730276 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.21454744 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21367309 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17010731 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16204683 |
| 44 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14503853 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06834441 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03593904 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.02512201 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01779810 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99515074 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98623602 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97325608 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 0.95885765 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.95735523 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93833781 |
| 55 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.93556499 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91437174 |
| 57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90976062 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89643305 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89568367 |
| 60 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.86694851 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86641366 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.85738390 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84173695 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.80599815 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80520349 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79616543 |
| 67 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.78954257 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77484283 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77227381 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77099757 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73898360 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72340716 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71616614 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70155989 |
| 75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.68959606 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68545047 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66419053 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65606405 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.64217038 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.62881520 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61472764 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60869328 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58961768 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.56178706 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55339060 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55284379 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.54186487 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50808135 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50680169 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48769798 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47306290 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45143865 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44161138 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43503131 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42009953 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41024313 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39486200 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.38450254 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37602195 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37020874 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36895061 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36144191 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.35903834 |
| 104 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35529571 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.34653741 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33283486 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.32867090 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32537163 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31885370 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31396123 |
| 111 | Gap junction_Homo sapiens_hsa04540 | 0.31190034 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31155379 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27609142 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25411182 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25211239 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.24334215 |
| 117 | Purine metabolism_Homo sapiens_hsa00230 | 0.23559666 |
| 118 | Melanogenesis_Homo sapiens_hsa04916 | 0.22400678 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21300749 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19721423 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.19552961 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19524319 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19259047 |
| 124 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.18823974 |

